Reflex control of rat tail sympathetic nerve activity by abdominal temperature.

The thermoregulatory reflex effects of warming and cooling in the abdomen were investigated in 4 urethane-anesthetized Sprague-Dawley rats. Animals were shaved and surrounded by a water-perfused silastic jacket. Skin temperature under the jacket was recorded by thermocouples at 3 sites and brain temperature was monitored by a thermocouple inserted lateral to the hypothalamus. A heat exchanger made from an array of silicon tubes in parallel loops was placed through a ventral incision into the abdomen; it rested against the intestinal serosa and the temperature of this interface was monitored by a thermocouple. Few- or multi-unit postganglionic activity was recorded from sympathetic nerves supplying tail vessels (tail SNA). Intra-abdominal temperature was briefly lowered or raised between 35-41 °C by perfusing the heat exchanger with cold or warm water. Warming the abdomen inhibited tail SNA while cooling it excited tail SNA in all 4 animals. We also confirmed that cooling the trunk skin activated tail SNA. Multivariate analysis of tail SNA with respect to abdominal, brain and trunk skin temperatures revealed that all had highly significant independent inhibitory actions on tail SNA, but in these experiments abdominal temperature had the weakest and brain temperature the strongest effect. We conclude that abdominal temperature has a significant thermoregulatory action in the rat, but its influence on cutaneous vasomotor control appears to be weaker than that of skin or brain temperatures

Calibration of thresholds for functional engagement of vagal A, B and C fiber groups in vivo.

Vagal nerve stimulation is widely used therapeutically but the fiber groups activated are often unknown. Aim: To establish a simple protocol to define stimulus thresholds for vagal A, B and C fibers. Methods: The intact left or right cervical vagus was stimulated with 0.1 ms pulses in spontaneously breathing anesthetized rats. Heart and respiratory rate responses to vagal stimulation were recorded. The vagus was subsequently cut distally, and mass action potentials to the same stimuli were recorded. Results: Stimulating at either 50 Hz for 2 s or 2 Hz for 10 s at experimentally determined strengths revealed A, B and C fiber thresholds that were related to respiratory and heart rate changes. Conclusion: Our simple protocol discriminates vagal A, B and C fiber thresholds in vivo

Paraventricular Nucleus Modulates Excitatory Cardiovascular Reflexes during Electroacupuncture

The paraventricular nucleus (PVN) regulates sympathetic outflow and blood pressure. Somatic afferent stimulation activates neurons in the hypothalamic PVN. Parvocellular PVN neurons project to sympathoexcitatory cardiovascular regions of the rostral ventrolateral medulla (rVLM). Electroacupuncture (EA) stimulates the median nerve (P5-P6) to modulate sympathoexcitatory responses. We hypothesized that the PVN and its projections to the rVLM participate in the EA-modulation of sympathoexcitatory cardiovascular responses. Cats were anesthetized and ventilated. Heart rate and mean blood pressure were monitored. Application of bradykinin every 10-min on the gallbladder induced consistent pressor reflex responses. Thirty-min of bilateral EA stimulation at acupoints P5-P6 reduced the pressor responses for at least 60-min. Inhibition of the PVN with naloxone reversed the EA-inhibition. Responses of cardiovascular barosensitive rVLM neurons evoked by splanchnic nerve stimulation were reduced by EA and then restored with opioid receptor blockade in the PVN. EA at P5-P6 decreased splanchnic evoked activity of cardiovascular barosensitive PVN neurons that also project directly to the rVLM. PVN neurons labeled with retrograde tracer from rVLM were co-labeled with μ-opioid receptors and juxtaposed to endorphinergic fibers. Thus, the PVN and its projection to rVLM are important in processing acupuncture modulation of elevated blood pressure responses through a PVN opioid mechanism

Ghrelin and motilin receptors as drug targets for gastrointestinal disorders

G.J.S. is currently in receipt of a student CASE award from the British Biotechnology Science Research Council, sponsored by GlaxoSmithKline, and receives research funding from Takeda Pharmaceuticals